Investigating the progression of heart disease in diverse populations
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), COORDINATING CENTER - TASK AREA A - CORE STUDY OPERATIONS
['FUNDING_OTHER'] · UNIVERSITY OF WASHINGTON · NIH-11310389
This study is looking at heart health in a diverse group of men and women aged 45-84 who don't have any symptoms, using tests like CT scans and MRIs to see how their hearts and blood vessels are doing over time.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11310389 on ClinicalTrials.gov |
What this research studies
The Multi-Ethnic Study of Atherosclerosis (MESA) examines the early signs and risk factors of cardiovascular disease in a diverse group of men and women aged 45-84 who initially showed no symptoms. Participants undergo various imaging tests, including CT scans and MRIs, to assess heart and blood vessel health, alongside evaluations of lifestyle, genetics, and other health markers. The study aims to track changes over time and identify predictors of heart disease progression, providing valuable insights into cardiovascular health.
Who could benefit from this research
Good fit: Ideal candidates for this research are men and women aged 45-84 with no prior evidence of clinical cardiovascular disease.
Not a fit: Patients who are younger than 45 or those with existing clinical cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for early detection and prevention of cardiovascular disease in diverse populations.
How similar studies have performed: Previous studies on similar populations have shown promising results in understanding cardiovascular disease progression, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MCCLELLAND, ROBYN LEAGH — UNIVERSITY OF WASHINGTON
- Study coordinator: MCCLELLAND, ROBYN LEAGH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: atherosclerotic coronary disease